Alector Inc.

17.37-2.26-11.51%Vol 972.47K1Y Perf -25.79%
Apr 9th, 2021 16:00 DELAYED
BID17.33 ASK17.36
Open19.19 Previous Close19.63
Pre-Market- After-Market-
 - -  - -%
Target Price
33.80 
Analyst Rating
Strong Buy 1.07
Potential %
94.59 
Finscreener Ranking
★★★★     53.58
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★+     50.68
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★     59.67
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap1.38B 
Earnings Rating
Buy
Price Range Ratio 52W %
32.01 
Earnings Date
12th May 2021

Today's Price Range

17.0719.19

52W Range

9.1234.89

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-13.15%
1 Month
-0.74%
3 Months
12.79%
6 Months
71.64%
1 Year
-25.79%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ALEC17.37-2.2600-11.51
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Financial StrengthValueIndustryS&P 500US Markets
6.10
6.20
0.14
0.19
-
Leverage Ratio 1.70
ProfitabilityValueIndustryS&P 500US Markets
-
-785.60
-754.20
-1 217.80
-
RevenueValueIndustryS&P 500US Markets
13.93M
0.17
13.76
-
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.61-0.66-8.20
Q03 2020-0.54-0.67-24.07
Q02 2020-0.52-0.58-11.54
Q01 2020-0.48-0.53-10.42
Q04 2019-0.44-0.45-2.27
Q03 2019-0.42-0.47-11.90
Q02 2019-0.33-0.36-9.09
Q01 2019-0.30-0.42-40.00
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.662.94Positive
6/2021 QR-0.682.86Positive
12/2021 FY-2.82-10.59Negative
12/2022 FY-2.81-4.46Negative
Next Report Date12th May 2021
Estimated EPS Next Report-0.66
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume972.47K
Shares Outstanding79.58M
Trades Count13.27K
Dollar Volume11.30M
Avg. Volume642.65K
Avg. Weekly Volume644.75K
Avg. Monthly Volume843.56K
Avg. Quarterly Volume658.91K

Alector Inc. (NASDAQ: ALEC) stock closed at 17.37 per share at the end of the most recent trading day (a -11.51% change compared to the prior day closing price) with a volume of 972.83K shares and market capitalization of 1.38B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 171 people. Alector Inc. CEO is Arnon Rosenthal.

The one-year performance of Alector Inc. stock is -25.79%, while year-to-date (YTD) performance is 14.81%. ALEC stock has a five-year performance of %. Its 52-week range is between 9.12 and 34.89, which gives ALEC stock a 52-week price range ratio of 32.01%

Alector Inc. currently has a PE ratio of -8.20, a price-to-book (PB) ratio of 5.99, a price-to-sale (PS) ratio of 112.86, a price to cashflow ratio of 10.70, a PEG ratio of 2.32, a ROA of -40.15%, a ROC of -54.13% and a ROE of -79.34%. The company’s profit margin is -%, its EBITDA margin is -754.20%, and its revenue ttm is $13.93 Million , which makes it $0.17 revenue per share.

Of the last four earnings reports from Alector Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.66 for the next earnings report. Alector Inc.’s next earnings report date is 12th May 2021.

The consensus rating of Wall Street analysts for Alector Inc. is Strong Buy (1.07), with a target price of $33.8, which is +94.59% compared to the current price. The earnings rating for Alector Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Alector Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Alector Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 12.36, ATR14 : 1.42, CCI20 : -23.91, Chaikin Money Flow : -0.03, MACD : -0.26, Money Flow Index : 39.69, ROC : 5.35, RSI : 51.64, STOCH (14,3) : 53.91, STOCH RSI : 1.00, UO : 44.25, Williams %R : -46.09), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Alector Inc. in the last 12-months were: Calvin Yu (Sold 1 343 shares of value $41 981 ), Robert King (Sold 15 000 shares of value $404 958 ), Robert Paul (Option Excercise at a value of $1 124 150), Robert Paul (Sold 174 225 shares of value $3 494 497 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (85.71 %)
6 (85.71 %)
6 (85.71 %)
Moderate Buy
1 (14.29 %)
1 (14.29 %)
1 (14.29 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.07
Strong Buy
1.07
Strong Buy
1.07

Alector Inc.

Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain.

CEO: Arnon Rosenthal

Telephone: +1 415 231-5660

Address: 131 Oyster Point Boulevard, South San Francisco 94080, CA, US

Number of employees: 171

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

64%36%

Bearish Bullish

48%52%

Bearish Bullish

44%56%

News

Stocktwits